C. Ormazábal
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Immunology and Allergy top 10%
- Cell Adhesion Molecules Research
Papers in
- Oncology 5
- Bone health and treatments 4
- Cancer Diagnosis and Treatment 2
-
- Bone Metabolism and Diseases 2
- TGF-β signaling in diseases 1
- Co-authors
- Fernando Lecanda (9 shared papers)Carolina Zandueta (9 shared papers)Karmele Valencia (8 shared papers)Susana Martínez-Canarias (7 shared papers)Iker Antón (5 shared papers)Diego Luis-Ravelo (5 shared papers)Javier De Las Rivas (5 shared papers)Eva Bandrés (2 shared papers)
- Journals
- Molecular Oncology (1 paper)Bone (1 paper)Clinical Cancer Research (1 paper)Translational Oncology (1 paper)Oncogene (1 paper)
- Partner nations
- SpainUnited KingdomBelgium
In The Last Decade
C. Ormazábal
12 papers receiving 515 citations
Peers
Comparison fields: 5 of 52
- Cancer Research 181
- Immunology and Allergy 72
- Hematology 67
- Oncology 154
- Genetics 46
Countries citing papers authored by C. Ormazábal
This map shows the geographic impact of C. Ormazábal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Ormazábal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Ormazábal more than expected).
Fields of papers citing papers by C. Ormazábal
This network shows the impact of papers produced by C. Ormazábal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Ormazábal. The network helps show where C. Ormazábal may publish in the future.
Co-authors
The 25 scholars most cited alongside C. Ormazábal, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 148 | |
| 2 | 2012 | 124 | |
| 3 | 2012 | 46 | |
| 4 | 2012 | 46 | |
| 5 | 2016 | 42 | |
| 6 | 2013 | 37 | |
| 7 | 2012 | 28 | |
| 8 | 2012 | 19 | |
| 9 | 2012 | 15 | |
| 10 | 2017 | 9 | |
| 11 | 2010 | 7 | |
| 12 | 2013 | 1 |
About C. Ormazábal
C. Ormazábal is a scholar working on Oncology, Molecular Biology, Genetics, Hematology and Cancer Research, having authored 12 papers that have together received 522 indexed citations. Recurring topics across this work include Bone health and treatments (4 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers), Chronic Myeloid Leukemia Treatments (2 papers), Bone Metabolism and Diseases (2 papers), Cancer Diagnosis and Treatment (2 papers), MicroRNA in disease regulation (2 papers), Sarcoma Diagnosis and Treatment (1 paper) and TGF-β signaling in diseases (1 paper). The work is most often cited by research in Cancer Research (181 citations), Immunology and Allergy (72 citations), Hematology (67 citations), Oncology (154 citations) and Genetics (46 citations). C. Ormazábal has collaborated with scholars based in Spain, United Kingdom and Belgium. Frequent co-authors include Fernando Lecanda, Carolina Zandueta, Karmele Valencia, Susana Martínez-Canarias, Iker Antón, Diego Luis-Ravelo, Javier De Las Rivas, Eva Bandrés, Luis M. Montuenga and Elizabeth Guruceaga. Their work appears in journals such as Molecular Oncology, Bone, Clinical Cancer Research, Translational Oncology and Oncogene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.